Isolation and analysis of candidate myeloid tumor suppressor genes from a commonly deleted segment of 7q22.

[1]  M. Loh,et al.  Mutations in PTPN11 implicate the SHP-2 phosphatase in leukemogenesis. , 2004, Blood.

[2]  N. Ueda,et al.  Molecular Characterization of a Phospholipase D Generating Anandamide and Its Congeners* , 2004, Journal of Biological Chemistry.

[3]  Xin Wu,et al.  A specific splicing variant of SVH, a novel human armadillo repeat protein, is up-regulated in hepatocellular carcinomas. , 2003, Cancer research.

[4]  Junjun Zhang,et al.  Human Chromosome 7: DNA Sequence and Biology , 2003, Science.

[5]  William Kim,et al.  The von Hippel-Lindau tumor suppressor protein: new insights into oxygen sensing and cancer. , 2003, Current opinion in genetics & development.

[6]  Zhijian Qian,et al.  Expression profiling of CD34+ hematopoietic stem/ progenitor cells reveals distinct subtypes of therapy-related acute myeloid leukemia , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[7]  E. Green,et al.  MLL5, a homolog of Drosophila trithorax located within a segment of chromosome band 7q22 implicated in myeloid leukemia , 2002, Oncogene.

[8]  J. Hara,et al.  Establishment of a Monosomy 7 Leukemia Cell Line, MONO-7, With aras Gene Mutation , 2002, International journal of hematology.

[9]  F. Zindy,et al.  Dmp1 is haplo-insufficient for tumor suppression and modifies the frequencies of Arf and p53 mutations in Myc-induced lymphomas. , 2001, Genes & development.

[10]  E. Green,et al.  Candidate gene isolation and comparative analysis of a commonly deleted segment of 7q22 implicated in myeloid malignancies. , 2001, Genomics.

[11]  S. Reed,et al.  Human F-box protein hCdc4 targets cyclin E for proteolysis and is mutated in a breast cancer cell line , 2001, Nature.

[12]  S. Elledge,et al.  Phosphorylation-Dependent Ubiquitination of Cyclin E by the SCFFbw7 Ubiquitin Ligase , 2001, Science.

[13]  D. Largaespada,et al.  Modeling myeloid leukemia tumor suppressor gene inactivation in the mouse. , 2001, Seminars in cancer biology.

[14]  I. Kurochkin,et al.  ALEX1, a novel human armadillo repeat protein that is expressed differentially in normal tissues and carcinomas. , 2001, Biochemical and biophysical research communications.

[15]  Michele Pagano,et al.  The F-box protein family , 2000, Genome Biology.

[16]  J. Herman,et al.  Aberrant methylation of gene promoters in cancer---concepts, misconcepts, and promise. , 2000, Journal of the National Cancer Institute.

[17]  J. Gribben,et al.  Immunoglobulin heavy-chain consensus probes for real-time PCR quantification of residual disease in acute lymphoblastic leukemia. , 2000, Blood.

[18]  John M. Maris,et al.  Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia , 1999, Nature Genetics.

[19]  A. Bradley,et al.  Congenital heart disease in mice deficient for the DiGeorge syndrome region , 1999, Nature.

[20]  S. Scherer,et al.  Delineation of multiple deleted regions in 7q in myeloid disorders , 1999, Genes, chromosomes & cancer.

[21]  James M. Roberts,et al.  The murine gene p27Kip1 is haplo-insufficient for tumour suppression , 1998, Nature.

[22]  D. Pinkel,et al.  Retention of wild‐type p53 in tumors from p53 heterozygous mice: reduction of p53 dosage can promote cancer formation , 1998, The EMBO journal.

[23]  N. Zeleznik-Le,et al.  Establishment and characterization of a megakaryoblast cell line with amplification of MLL , 1998, Leukemia.

[24]  P. Nowell,et al.  Molecular anatomy of chromosome 7q deletions in myeloid neoplasms: evidence for multiple critical loci. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[25]  S. Scherer,et al.  Molecular cytogenetic delineation of deletions and translocations involving chromosome band 7q22 in myeloid leukemias. , 1997, Blood.

[26]  E. Green,et al.  Cytogenetic and molecular delineation of a region of chromosome 7 commonly deleted in malignant myeloid diseases. , 1996, Blood.

[27]  S. Scherer,et al.  Molecular definition of a narrow interval at 7q22.1 associated with myelodysplasia. , 1996, Blood.

[28]  R. Larson,et al.  Therapy-related myeloid leukemia. , 2008, Seminars in oncology.

[29]  A. Bradley,et al.  Chromosome engineering in mice , 1995, Nature.

[30]  K. Shannon,et al.  Childhood monosomy 7: epidemiology, biology, and mechanistic implications. , 1995, Blood.

[31]  K. Shannon,et al.  Genetic analysis is consistent with the hypothesis that NF1 limits myeloid cell growth through p21ras , 1994 .

[32]  P. O'Connell,et al.  Monosomy 7 myeloproliferative disease in children with neurofibromatosis, type 1: epidemiology and molecular analysis. , 1992, Blood.

[33]  E. Liu,et al.  Mutations of the ras proto-oncogenes in childhood monosomy 7. , 1991, Blood.

[34]  J. Kere,et al.  Chromosome 7 long-arm deletions in myeloid disorders: terminal DNA sequences are commonly conserved and breakpoints vary. , 1989, Cytogenetics and cell genetics.

[35]  J. Kere,et al.  Molecular characterization of chromosome 7 long arm deletions in myeloid disorders. , 1987, Blood.

[36]  R. Larson,et al.  Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes no. 5 and 7. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.